The present invention relates to a new pharmaceutical composition of fesoterodine or a salt or a solvate thereof, in particular to a dry formulation. The present invention relates to a new process for the preparation of dry formulation of fesoterodine or a salt or a solvate thereof. The pharmaceutical composition is particularly useful as a medicament, especially for the treatment of urinary incontinence.